You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on CypComp Database.
Record Information
Version1.0
Creation Date2019-07-14 16:35:11 UTC
Last Updated2019-10-01 21:40:53 UTC
CypComp IDCC01839
Compound Information
NameCMV423
Structure ImageKngxenhwynlkbu uhfffaoysa n
InChIKeyKNGXENHWYNLKBU-UHFFFAOYSA-N
PubChem ID489128
CypCompound Information
SetCypBoM Training Set
Bonds of Metabolism (BoMs)
CYP1A2CYP2A6CYP2B6CYP2C8CYP2C9CYP2C19CYP2D6CYP2E1CYP3A4
  • <13,H;Hydroxylation;R1>
  • Not Available
  • Not Available
  • <3,N;N-Oxidation;R1>
  • <13,H;Hydroxylation;R2>
  • <13,H;Hydroxylation;R1>
  • Not Available
  • Not Available
  • Not Available
  • <13,H;Hydroxylation;R1>
References
  1. Bournique B, Lambert N, Boukaiba R, Martinet M: In vitro metabolism and drug interaction potential of a new highly potent anti-cytomegalovirus molecule, CMV423 (2-chloro 3-pyridine 3-yl 5,6,7,8-tetrahydroindolizine I-carboxamide). Br J Clin Pharmacol. 2001 Jul;52(1):53-63. doi: 10.1046/j.0306-5251.2001.01413.x. [PubMed:11453890 ]
Download FileCC01839.sdf